
1. Malar J. 2015 Jun 4;14:233. doi: 10.1186/s12936-015-0748-6.

Development of a genetic tool for functional screening of anti-malarial bioactive
extracts in metagenomic libraries.

Mongui A(1)(2), Pérez-Llanos FJ(3)(4), Yamamoto MM(5), Lozano M(6), Zambrano
MM(7), Del Portillo P(8), Fernández-Becerra C(9), Restrepo S(10), Del Portillo
HA(11)(12), Junca H(13)(14).

Author information: 
(1)RG Microbial Ecology: Metabolism, Genomics & Evolution - CorpoGen, Bogotá,
Colombia. amonguic@gmail.com.
(2)Department of Biological Sciences, Universidad de los Andes, Bogotá, Colombia.
amonguic@gmail.com.
(3)RG Microbial Ecology: Metabolism, Genomics & Evolution - CorpoGen, Bogotá,
Colombia. francisjpll@gmail.com.
(4)Department of Biological Sciences, Universidad de los Andes, Bogotá, Colombia.
francisjpll@gmail.com.
(5)Departamento de Parasitologia, Universidade de São Paulo, São Paulo, Brazil.
masayama@gmail.com.
(6)RG Microbial Ecology: Metabolism, Genomics & Evolution - CorpoGen, Bogotá,
Colombia. macheperez@hotmail.com.
(7)RG Microbial Ecology: Metabolism, Genomics & Evolution - CorpoGen, Bogotá,
Colombia. mzambrano@corpogen.org.
(8)RG Microbial Ecology: Metabolism, Genomics & Evolution - CorpoGen, Bogotá,
Colombia. pdelportillo@corpogen.org.
(9)ICREA at ISGlobal, Barcelona Ctr Int Health Res (CRESIB), Hospital Clínic -
Universitat de Barcelona, Barcelona, Spain. carmen.fernandez@cresib.cat.
(10)Department of Biological Sciences, Universidad de los Andes, Bogotá,
Colombia. srestrep@uniandes.edu.co.
(11)ICREA at ISGlobal, Barcelona Ctr Int Health Res (CRESIB), Hospital Clínic -
Universitat de Barcelona, Barcelona, Spain. hernandoa.delportillo@cresib.cat.
(12)Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain. 
hernandoa.delportillo@cresib.cat.
(13)RG Microbial Ecology: Metabolism, Genomics & Evolution - CorpoGen, Bogotá,
Colombia. info@howardjunca.com.
(14)Present Address: Applied Biology Program, Faculty of Basic & Applied
Sciences, Universidad Militar Nueva Granada-UMNG, Campus Cajicá, Bogotá, DC,
Colombia. info@howardjunca.com.

BACKGROUND: The chemical treatment of Plasmodium falciparum for human infections 
is losing efficacy each year due to the rise of resistance. One possible strategy
to find novel anti-malarial drugs is to access the largest reservoir of genomic
biodiversity source on earth present in metagenomes of environmental microbial
communities.
METHODS: A bioluminescent P. falciparum parasite was used to quickly detect
shifts in viability of microcultures grown in 96-well plates. A synthetic gene
encoding the Dermaseptin 4 peptide was designed and cloned under tight
transcriptional control in a large metagenomic insert context (30 kb) to serve as
proof-of-principle for the screening platform.
RESULTS: Decrease in parasite viability consistently correlated with
bioluminescence emitted from parasite microcultures, after their exposure to
bacterial extracts containing a plasmid or fosmid engineered to encode the
Dermaseptin 4 anti-malarial peptide.
CONCLUSIONS: Here, a new technical platform to access the anti-malarial potential
in microbial environmental metagenomes has been developed.

DOI: 10.1186/s12936-015-0748-6 
PMCID: PMC4464701
PMID: 26040274  [Indexed for MEDLINE]

